|
Pfizer Discontinues Global Phase III Trial of Axitinib
|
31 January 2009 |
|
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
|
26 January 2009 |
|
Pfizer Receives FDA Complete Response Letter for Lasofoxifene
|
17 January 2009 |
|
U.S. Patent and Trademark Office Accepts Pfizer's Reissue Application on Lipitor
|
06 January 2009 |
|
Pfizer and Sigma-Tau Announce an Agreement to Market a Potential New Treatment for Malaria
|
10 December 2008 |
|
Pfizer's Novel HIV/AIDS Treatment SELZENTRY™
|
27 November 2008 |
|
Pfizer withdraws its application to change the marketing authorisation for Viagra
|
20 November 2008 |
|
Pfizer Launches Global Regenerative Medicine Research Unit
|
14 November 2008 |
|
Pfizer and UCB Announce Formation of New Company Cyclofluidic to Accelerate Drug Discovery Process
|
21 October 2008 |
|
Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications
|
17 October 2008 |
|
Pfizer Launches New Medicine Safety Website for Healthcare Professionals and Patients
|
22 September 2008 |
|
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
|
10 September 2008 |
|
Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market Dimebon
|
04 September 2008 |
|
IAFF Launches Smoking Cessation Campaign with Pfizer
|
12 August 2008 |
|
Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke
|
07 August 2008 |
|
Pfizer Reports Second-Quarter 2008 Results
|
24 July 2008 |
|
Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows
|
08 July 2008 |
|
Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide
|
20 June 2008 |
|
Pfizer Celebrates 5 Years of High-Impact Corporate Volunteer Missions
|
16 June 2008 |
|
Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.
|
12 June 2008 |